Brain parenchyma sonography detects preclinical parkinsonism

Mov Disord. 2004 Dec;19(12):1445-9. doi: 10.1002/mds.20232.

Abstract

Substantia nigra (SN) hyperechogenicity on brain parenchyma sonography (BPS) is highly characteristic for idiopathic PD. We studied 7 symptomatic and 7 asymptomatic parkin mutation carriers (PMC) from a large kindred with adult-onset parkinsonism. BPS revealed larger SN echogenic sizes in PMC with parkin mutations on both alleles (homozygous, compound-heterozygous), compared to PMC with only one mutated allele (Mann-Whitney U test, P = 0.007). In symptomatic PMC, larger SN echogenic size was correlated with younger age at onset of the disease (Spearman rank correlation, Rho = -0.937, P = 0.002) but not with age, disease duration, or disease severity. BPS demonstrated SN hyperechogenicity, in concordance with abnormal nigrostriatal (18)F-dopa positron emission tomography (PET), in all symptomatic and 3 asymptomatic PMC. In 2 asymptomatic PMC, PET and BPS were normal. However, in another 2 asymptomatic PET-normal PMC, SN hyperechogenicity could be detected. Data suggest SN hyperechogenicity as an early marker to detect preclinical parkinsonism.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Brain / pathology
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease / diagnostic imaging*
  • Parkinson Disease / genetics
  • Parkinson Disease / pathology
  • Point Mutation / genetics
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Substantia Nigra / diagnostic imaging
  • Substantia Nigra / metabolism
  • Ubiquitin-Protein Ligases / genetics
  • Ultrasonography

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Ubiquitin-Protein Ligases
  • parkin protein